Literature DB >> 1993745

Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.

J A Englund1, L J Anderson, F S Rhame.   

Abstract

Respiratory syncytial virus (RSV) isolates obtained from nine infected immunocompromised adult patients hospitalized during two consecutive winters (January through April 1987 and 1988) were collected and analyzed against a panel of monoclonal antibodies by an enzyme immunoassay. The history of the patients' illness, onset of symptoms, and date of initial isolation of virus was correlated with the hospital ward and time of hospitalization. Three patients died of respiratory failure related to RSV infection acquired nosocomially. A cluster of RSV disease in four patients hospitalized simultaneously during the 1987 season was demonstrated to be caused by four antigenically distinct viruses; despite an epidemiologic link among the patients, each had been infected from a different source. The RSV disease in the five immunocompromised adults in 1988 was caused by two distinct strains; three patients were infected with RSV subgroup A/4, and two were infected with RSV subgroup B/2. Combining the epidemiologic and strain characterization studies, none of four patients in 1987 were infected from each other, and two of five patients in 1988 may have been infected, directly or indirectly, from one of the other five. The strain characterization studies demonstrated the potential complexity of RSV nosocomial transmission and the need to consider a number of sources for transmission in developing effective prevention strategies. The three deaths underscore the importance of nosocomial RSV disease and the importance of effective prevention strategies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993745      PMCID: PMC269714          DOI: 10.1128/jcm.29.1.115-119.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

Review 1.  Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.

Authors:  M Fishaut; D Tubergen; K McIntosh
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

2.  Modes of transmission of respiratory syncytial virus.

Authors:  C B Hall; R G Douglas
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

3.  Hospital cross-infection on children's wards with respiratory syncytial virus and the role of adult carriage.

Authors:  D G Sims; M A Downham; J K Webb; P S Gardner; D Weightman
Journal:  Acta Paediatr Scand       Date:  1975-05

4.  Control of nosocomial respiratory syncytial viral infections.

Authors:  C B Hall; J M Geiman; R G Douglas; M P Meagher
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

5.  Respiratory syncytial viral infection in infants with congenital heart disease.

Authors:  N E MacDonald; C B Hall; S C Suffin; C Alexson; P J Harris; J A Manning
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

6.  Nosocomial respiratory syncytial virus infections.

Authors:  C B Hall; R G Douglas; J M Geiman; M K Messner
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

7.  Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987.

Authors:  R M Hendry; L T Pierik; K McIntosh
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

8.  Respiratory syncytial virus infections in infants: quantitation and duration of shedding.

Authors:  C B Hall; R G Douglas; J M Geiman
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

9.  Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors.

Authors:  W M Valenti; T A Clarke; C B Hall; M A Menegus; D L Shapiro
Journal:  J Pediatr       Date:  1982-05       Impact factor: 4.406

10.  Respiratory syncytial virus in hospital cross-infection.

Authors:  R K Ditchburn; J McQuillin; P S Gardner; S D Court
Journal:  Br Med J       Date:  1971-09-18
View more
  26 in total

1.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication.

Authors:  Alfonsina Trento; Mariana Viegas; Mónica Galiano; Cristina Videla; Guadalupe Carballal; Alicia S Mistchenko; José A Melero
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.

Authors:  Kalina T Zlateva; Philippe Lemey; Elien Moës; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 5.  Health care-acquired viral respiratory diseases.

Authors:  William P Goins; H Keipp Talbot; Thomas R Talbot
Journal:  Infect Dis Clin North Am       Date:  2011-03       Impact factor: 5.982

6.  Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR.

Authors:  David M Whiley; Melanie W Syrmis; Ian M Mackay; Theo P Sloots
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 7.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 8.  Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions.

Authors:  D A Goldmann
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

9.  Evaluation of a commercial enzyme immunomembrane filter assay for detection of respiratory syncytial virus in clinical specimens.

Authors:  D Van Beers; M De Foor; L Di Cesare; C Vandenvelde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

10.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

Authors:  J A Englund; P A Piedra; A Jewell; K Patel; B B Baxter; E Whimbey
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.